Organization Announcements

Organization Announcements


Paul G. Allen Frontiers Group [to 13 Feb 2021]
No new digest content identified.


BARDA – U.S. Department of HHS [to 13 Feb 2021]
February 11, 2021
Biden Administration purchases additional doses of COVID-19 vaccines from Pfizer and Moderna
The U.S. Department of Health and Human Services (HHS) and Department of Defense (DOD) have purchased an additional 100 million doses of COVID-19 vaccines from both Pfizer Inc. and Moderna Inc. to help meet demand for COVID-19 vaccines in the United States.
The orders placed today bring the vaccine purchased by the U.S. government from these two companies to a total of 600 million doses, enough to vaccinate 300 million people. Each company is delivering 300 million doses in regular increments through the end of July 2021. Each company will leverage U.S.-based manufacturing capacity to fill, finish and ship vials as the bulk material is produced.
“As the President directed, we are expanding our supply of COVID vaccines to protect people as quickly as possible,” said Acting HHS Secretary Norris Cochran. “These purchases will allow us to accelerate our vaccination efforts to get shots into the arms of the American people. While we rapidly ramp up the pace of vaccinations, I encourage everyone to take actions now to protect themselves and their families: wear a mask, wash your hands often, and practice physical distancing.”…


BMGF – Gates Foundation [to 13 Feb 2021]
Press Releases and Statements
No new digest content identified.


Bill & Melinda Gates Medical Research Institute [to 13 Feb 2021]
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.


CARB-X [to 13 Feb 2021]
No new digest content identified.


Center for Vaccine Ethics and Policy – GE2P2 Global Foundation [to 13 Feb 2021]
Past weekly editions of Vaccines and Global Health: The Week in Review are available here.


CEPI – Coalition for Epidemic Preparedness Innovations [to 13 Feb 2021]
Latest News
08 Feb 2021
COVAX Statement on New Variants of SARS-CoV-2
The emergence of variants of SARS-CoV-2, the virus that causes COVID-19,  serve as a powerful reminder that viruses by their very nature mutate, and that the scientific response may need to adapt if they are to remain effective against them.
[See COVID above for detail]


DARPA – Defense Advanced Research Projects Agency [to 13 Feb 2021
DARPA Program to Offer Near Immediate Doses of Vaccine, Therapeutics for Infectious Diseases
Nucleic acids On-demand Worldwide (NOW) will allow for rapid and distributed manufacturing of nucleic acid-based medical countermeasures
The U.S. military routinely deploys throughout the world where warfighters can potentially be exposed to regional endemic diseases as well as chemical, biological, radiological, or nuclear (CBRN) threats. Rapid access to medical countermeasures (MCMs) against these threats is critical to protect Defense Department (DoD) personnel and local populations; however, manufacturing, stockpiling, and distribution issues remain.

To address these challenges, DARPA has established the Nucleic acids On-demand Worldwide (NOW) program to develop a mobile MCM manufacturing platform to rapidly produce, formulate, and package hundreds of doses of nucleic acid therapeutics in days – rather than months or years. The system promises to provide significant advancement over current cell-based methods, and the resulting product could allow for end-to-end synthesis of Good Manufacturing Practice (GMP) quality material, even in austere environments. The mobile nature of the NOW platform aims to provide immediate threat response anywhere the military operates, mitigate surprise from infectious disease threats, and ensure a resilient, readily accessible nucleic acid MCM manufacturing pipeline.

“This mobile manufacturing system is designed to fit into a CONEX box and taken ‘on the go’ for stabilization and humanitarian missions in addition to traditional military operations,” noted Dr. Amy Jenkins, NOW program manager. “The ability to manufacture therapeutics on-site is a huge advantage in time to produce a product and reduction in logistical burden.”

The NOW program will be organized into three phases. In the 36-month Phase 1, performers will investigate new bio/chemical methods to synthesize nucleic acids (Technical Area 1), and explore downstream purification, analysis, and formulation of newly synthesized material (Technical Area 2). A 12-month Phase 2 will focus on system integration to finalize a contained, end-to-end mobile manufacturing platform. In coordination with the U.S. FDA, the 12-month Phase 3 will focus on a human clinical study that directly compares a NOW-derived product with traditionally-manufactured material. This will demonstrate full platform functionality while producing an MCM targeting a DoD relevant disease indication.

Contracts have been awarded to Moderna, Inc. and GE Research to advance the goals of the program.
“These teams are well positioned to combine the novel approaches to nucleic acid cell free synthesis and the required system engineering approaches for a distributed manufacturing system to ensure the NOW program requirements are met,” noted Jenkins. “Upon program completion, the NOW platform could have important commercial applications by providing increased MCM production and manufacturing during periods of high demand.”

Additional details of the program schedule and metrics are available in the 2019 broad agency announcement at

Duke Global Health Innovation Center [to 13 Feb 2021]
Launch and Scale Speedometer
No new digest content identified.


EDCTP [to 13 Feb 2021]
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
11 February 2021
A suitcase-sized laboratory for rapid detection of SARS-COV-2 in Africa
The PCR test is the most accurate tool to identify SARS-CoV-2, the virus causing COVID-19. However, valid results are often available only after days. Moreover, the laboratory must be well equipped, have trained personnel and sufficient financial resources. In cooperation with several African universities, a study led by virologist Dr Ahmed Abd El Wahed, Leipzig University, found that a small, mobile laboratory fitting in a suitcase delivers test results that are almost as good as a PCR test and are delivered almost in real-time. EDCTP supported the clinical evaluation with a COVID-19 Emergency grant of €500,000…


Emory Vaccine Center [to 13 Feb 2021]
Vaccine Center News
No new digest content identified.


European Commission [to 13 Feb 2021]
Press release 11 February 2021
New EU programme to support readiness for vaccination efforts in Eastern Partnership countries with WHO
Today, the EU in partnership with the World Health Organisation (WHO) launched a new regional programme worth over €40 million to provide critical assistance to ensure local readiness and preparedness for safe and effective vaccination of the population in the six Eastern Partnership countries: Armenia, Azerbaijan, Belarus, Georgia, the Republic of Moldova and Ukraine.

Speech 10 February 2021
Remarks by Commissioner Stella Kyriakides in the Plenary of the European Parliament on the EU Vaccine Strategy
Remarks by Commissioner Stella Kyriakides in the Plenary of the European Parliament on the EU Vaccine Strategy

Speech 10 February 2021
Speech by President von der Leyen at the European Parliament Plenary on the state of play of the EU’s COVID-19 Vaccination Strategy
The President of the Commission, Ursula von der Leyen, gave a speech at the European Parliament Plenary debate on the state of play of the EU’s COVID-19 Vaccination Strategy.


European Medicines Agency [to 13 Feb 2021]
News & Press Releases
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 February 2021
PRAC, Last updated: 12/02/2021



News: EMA starts rolling review of CureVac’s COVID-19 vaccine (CVnCoV)
Last updated: 12/02/2021
[See COVID coverage above for detail]



News: EMA preparing guidance to tackle COVID-19 variants
Last updated: 10/02/2021
[See COVID coverage above for detail]



News: Clarification on Sputnik V vaccine in the EU approval process
Last updated: 10/02/2021
[See COVID coverage above for detail]



News: International regulators working together to enhance collaboration on COVID-19 observational research
Last updated: 08/02/2021
[See COVID coverage above for detail]


European Vaccine Initiative [to 13 Feb 2021]
Latest News
11 Feb 2021
International Day of Women and Girls in Science 2021


FDA [to 13 Feb 2021]
Press Announcements /Selected Details
:: February 12, 2021 – Coronavirus (COVID-19) Update: February 12, 2021
…This week, the FDA posted the webpage, COVID-19 Vaccine Safety Surveillance, which provides an overview of our active and passive systems used to monitor the safety of authorized COVID-19 vaccines. The FDA’s Center for Biologics Evaluation and Research is conducting these surveillance efforts in collaboration with the Centers for Disease Control and Prevention, the Center for Medicare and Medicaid Services, the Department of Veterans Affairs, and other academic and large non-government healthcare data systems…


:: February 9, 2021 – Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19


:: February 9, 2021 – Coronavirus (COVID-19) Update: February 9, 2021


FDA – COVID-19 Vaccines [to 13 Feb 2021]
News and Updates; Upcoming Events
Coronavirus (COVID-19) Update
FDA issued an emergency use authorization (EUA) for the treatment of mild to moderate COVID-19 in adults and pediatric patients and also revised its guidance, Investigational COVID-19 Convalescent Plasma.


Fondation Merieux [to 13 Feb 2021]
News, Events
Mérieux Foundation co-organized event
MERACON: Returning to rabies elimination in 2021 webinar
February 26, 2021 – 9:00am -12:00pm (CET)
The COVID-19 pandemic has hampered global travel and has placed a strain on public health systems globally. Because of this, many rabies activities were postponed or cancelled in 2020. Similarly, the planned in-person regional MERACON workshop that was initially scheduled for mid-2020 was postponed to 2021. As a means to continue remote support, foster collaboration and continue to drive progress towards rabies elimination in the MERACON countries, the MERACON steering committee has scheduled a digital meeting in webinar format. This webinar will act as a precursor to a more detailed workshop later in the year which we hope to host in-person (COVID-19 restrictions permitting).


Gavi [to 13 Feb 2021]
News Releases
COVAX Statement on New Variants of SARS-CoV-2
8 February 2021
[See COVID above for detail]


GHIT Fund [to 13 Feb 2021]
GHIT was set up in 212 with the aim of developing new tools to tackle infectious diseases that
Press Releases
No new digest content identified.


Global Fund [to 13 Feb 2021]
News & Stories
Safely Reopening Requires Testing, Tracing and Isolation, Not Just Vaccines
11 February 2021
by Peter Sands, Executive Director of the Global Fund & Achim Steiner, UNDP Administrator

Protecting the most vulnerable in Latin America and the Caribbean during times of COVID-19
11 February 2021
Latin America and the Caribbean have made significant progress in the fight against HIV, tuberculosis and malaria in the last few decades. But the COVID-19 pandemic has hit the region hard, and its indirect effects could allow infectious diseases to resurge.


Global Research Collaboration for Infectious Disease Preparedness [GloPID-R] [to 13 Feb 2021]
GloPID-R and partners UKCDR & ISARIC further COVID-19 response
… The public website UKCDR–GloPID-R COVID CIRCLE Researcher Coordination Platform was launched to facilitate information sharing on COVID-19 research and bring together the global research community working on COVID-19 research, in and for low resource settings.
Key features of the platform are:
:: COVID-19 Resource hub: including the UKCDR & GloPID-R COVID-19 Research Projects Tracker, COVID-19 research reports, papers, guidance, tools and webinars collected from key organisations
:: Map of global and regional networks relevant to epidemics research
:: COVID-19 events from around the world including webinars, workshops and more…


Hilleman Laboratories [to 13 Feb 2021]
No new digest content identified.


Human Vaccines Project [to 13 Feb 2021]
Press Releases
One Shot or Two?
Akiko Iwasaki, Ph.D.
Professor of Immunobiology and Molecular, Cellular, and Developmental Biology
Yale School of Medicine
In response to the still limited supply of COVID-19 vaccines, governments, health departments, and scientists are evaluating various ways to stretch existing doses and vaccinate more of the global population as quickly as possible. This effort is particularly urgent given the concern over SARS-CoV-2 variants that are increasingly prevalent throughout the world. In some cases, this has meant delaying the second vaccine dose. But for individuals who have already had COVID, data suggest it may be possible to forego the second dose altogether. HVP Editor Kristen Jill Abboud recently spoke with Akiko Iwasaki, Professor of Immunobiology and Molecular, Cellular, and Developmental Biology at Yale School of Medicine, about establishing effective immunity in individuals who have recovered from COVID-19.


IAVI [to 13 Feb 2021]
February 12, 2021
Explainer videos: Understanding concepts of HIV vaccine development

February 9, 2021
Prevention revolution or miles away from our targets? A look back at HIV Research for Prevention

February 8, 2021
How can COVID-19 pave the way for global access pathways for monoclonal antibodies?



International Coalition of Medicines Regulatory Authorities [ICMRA]
Selected Statements, Press Releases, Research
No new digest content identified.



International Generic and Biosimilar Medicines Association [IGBA]
Press Releases/Announcements
No new digest content identified.



Press Releases/Announcements
No new digest content identified.


IFRC [to 13 Feb 2021]
Selected Press Releases, Announcements
No new digest content identified.


Institut Pasteur [to 13 Feb 2021]
Press release 12.02.2021
Heat islands and lack of running water promote dengue fever in Delhi, India
What if more inclusive urban planning for poor populations was key to fighting dengue fever? This is what researchers…

Press Info 12.02.2021
Comment: The tortuous path to ending the Covid-19 pandemic
The COVID-19 pandemic has devastated health-care systems, shut down schools and communities, and plunged the world into an economic recession. While 2020 was a challenging year, 2021 looks to be difficult with the emergence of multiple variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The race to vaccinate the world will need to respond to the pathogen’s constant evolution to evade immunity. What marks the path to the end of this pandemic?
Read the full comment in The Lancet – published on February 11, 2021


IRC International Rescue Committee [to 13 Feb 2021]
Media highlights [Selected]
No new digest content identified.


IVAC [to 13 Feb 2021]
Updates; Events
No new digest content identified.


IVI [to 13 Feb 2021]
Selected IVI News, Announcements, Events
No new digest content identified.


JEE Alliance [to 13 Feb 2021]
Selected News and Events
No new digest content identified.


Johns Hopkins Center for Health Security [to 13 Feb 2021]
Center News
Johns Hopkins Center for Health Security Launches a New Comprehensive Toolkit on COVID-19 Testing and Testing Services
February 11, 2021

New Report: Equity in Vaccination: A Plan to Work with Communities of Color Toward COVID-19 Recovery and Beyond
February 9, 2021


MSF/Médecins Sans Frontières [to 13 Feb 2021]
Latest [Selected Announcements]
Keeping an eye on COVID-19 cases in Herat, Afghanistan
Project Update 12 Feb 2021
Due to an increase in the number of people with severe COVID-19 in Herat, western Afghanistan, the Médecins Sans Frontières (MSF) COVID-19 treatment centre in Gazer Ga reopened on 2 December 2020…


National Vaccine Program Office – U.S. HHS [to 13 Feb 2021]
Upcoming Meetings/Latest Updates
No new digest content identified.


NIH [to 13 Feb 2021]
News Releases
Researchers propose that humidity from masks may lessen severity of COVID-19
February 12, 2021 — NIH study compares how different face masks affect humidity inside the mask.

Study Identifies Risk Factors for Elevated Anxiety in Young Adults During COVID-19 Pandemic
February 12, 2021 — Findings on impact of childhood temperament could help with anxiety prevention efforts.

NIH experts discuss SARS-CoV-2 viral variants
February 12, 2021 — Editorial emphasizes need for global response.

Four potential COVID-19 therapeutics enter Phase 2/3 testing in NIH ACTIV-2 trial
February 12, 2021 — The added sub-studies will test four interventions for safety and efficacy.

NIH calls for greater inclusion of pregnant and lactating people in COVID-19 vaccine research
February 10, 2021 — Longstanding obstacles to include pregnant and lactating people in clinical research have led to this population now deciding whether or not to receive a SARS-CoV-2 vaccine without the benefit of scientific evidence, writes Diana W. Bianchi, M.D., director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health, and colleagues. Their viewpoint article appears online in JAMA….

Clinical trial in hospitalized COVID-19 patients evaluates long-acting antibody therapy
February 8, 2021 — NIH trial has begun enrolling participants.


PATH [to 13 Feb 2021]
Press Release
No new digest content identified.


Sabin Vaccine Institute [to 13 Feb 2021]
Statements and Press Releases
Learning to Prevent the Next Pandemic: VaxHunt Game Earns Educational Trustmark
Monday, February 8, 2021


UNAIDS [to 13 Feb 2021]
Selected Press Releases/Reports/Statements
12 February 2021
People living with HIV in Kyrgyzstan have won the right to adopt

10 February 2021
Making a mark on the COVID-19 pandemic: joint efforts to meet the needs of young key populations in Asia and the Pacific

9 February 2021
How was a COVID-19 vaccine found so quickly?

8 February 2021
Provision of services for domestic violence uneven


UNHCR Office of the United Nations High Commissioner for Refugees [to 13 Feb 2021]
Selected Announcements
UNHCR and IOM welcome Colombia’s decision to regularize Venezuelan refugees and migrants
UNHCR–IOM Joint Press Release
8 Feb 2021
BOGOTA/GENEVA – UNHCR, the UN Refugee Agency and IOM, the International Organization for Migration, today praised Colombia’s initiative to provide ten-year temporary protection status to Venezuelans in the country…
The Temporary Protection Status will also provide access to basic services including the national health system and COVID-19 vaccination plans


UNICEF [to 13 Feb 2021]
Selected Press releases, Statements
Press release 02/07/2021
UNICEF deploys staff, medical equipment and supplies in response to new Ebola case in eastern DRC
UNICEF working with Government and partners in North Kivu province following announcement by the Ministry of Health of the death of a 42 year-old-mother


Unitaid [to 13 Feb 2021]
Featured News
No new digest content identified.


Vaccination Acceptance Research Network (VARN) [to 13 Feb 2021]
No new digest content identified.


Vaccine Confidence Project [to 13 Feb 2021]
News, Research and Reports
No new digest content identified.


Vaccine Education Center – Children’s Hospital of Philadelphia [to 13 Feb 2021]
No new digest content identified.


Wellcome Trust [to 13 Feb 2021]
Why we should involve more young people in health research
It is crucial to empower and support young people to shape health research, and this is why.
Anita Krishnamurthi, Head of Education and Learning
11 February 2021

Why we need a scientific approach to mental health at work
With businesses looking to support the mental health of their staff more than ever, Wellcome is urging them to take a science-based approach. Miranda Wolpert shares what we’ve learned so far about what works for supporting mental health at work.
Miranda Wolpert, Head of Mental Health
9 February 2021


The Wistar Institute [to 13 Feb 2021]
Press Releases
No new digest content identified.


WFPHA: World Federation of Public Health Associations [to 13 Feb 2021]
Latest News
No new digest content identified.


World Organisation for Animal Health (OIE) [to 13 Feb 2021]
Press Releases
No new digest content identified.





ARM [Alliance for Regenerative Medicine] [to 13 Feb 2021]
Press Releases – Alliance for Regenerative Medicine (
Press Releases
No new digest content identified.


BIO [to 13 Feb 2021]
Press Releases
No new digest content identified.


DCVMN – Developing Country Vaccine Manufacturers Network [to 13 Feb 2021]
News; Upcoming events
No new digest content identified.


ICBA – International Council of Biotechnology Associations [to 13 Feb 2021]
No new digest content identified.


IFPMA [to 13 Feb 2021]
Selected Press Releases, Statements, Publications
No new digest content identified.


PhRMA [to 13 Feb 2021]
Selected Press Releases, Statements
Lessons learned from COVID-19: The way we develop new medicines is changing
February 10, 2021
Richard Moscicki, M.D. serves as executive vice president, Science and Regulatory Advocacy and chief medical officer at PhRMA.
Early on in the pandemic, social distancing measures forced a rapid and widespread adoption of digital technologies to support safer communication between patients and providers. Researchers from Health Affairs studying data have found “during the pandemic, 30.1% of all visits were provided via telemedicine” and that weekly visits occurring for telemedicine rose exponentially from pre-COVID-19 levels.
Blog Post